Chronic sensing of the subthalamic nucleus in Parkinson’s disease patients: preliminary observations
Objective: Here we document the key advances and pitfalls of the PerceptTM PC (Medtronic), a commercially available device capable of recording brain local field potentials…Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
Objective: To evaluate whether the 123I-FP-CIT striatal uptake differs in Parkinson’s disease (PD) drug-naïve patients with and without sexual dysfunction. Background: Sexual dysfunction is one…Disentangling prodromal from non-prodromal symptoms of Parkinson’s disease
Objective: To define a subset of Parkinson’s disease (PD) symptoms that are present in both individuals with early PD and prodromal PD, compared with age-matched…Physical and mental fatigue in Parkinson’s Disease: analysis from COPPADIS database
Objective: To analyze the presence of fatigue and related factors in a Spanish Parkinson´s disease (PD) cohort and to compare with a control group. Background:…Self perceived impact of the SARS-COV 2 pandemic on motor, non motor and affective symptoms in Parkinson’s disease and parkinsonisms.
Objective: to evaluate the perceived impact of the SARS-COV 2 pandemic on own wellbeing in people with Parkinson’s disease and parkinsonism (PWP) in Italy. Background:…Effects of psychiatric tests on disease severity and nonmotor symptoms in early onset Parkinson’s Disease
Objective: Psychiatric tests evaluating symptoms such as depression, anxiety, rumination, obsession, impulsivity, apathy and impulsive compulsive behaviors were applied in patients with early onset PD.…Effects of levodopa dose on temporal dynamics of cortical activity and postural control in people with Parkinson’s disease
Objective: The purpose of this study was to evaluate the temporal dynamics of cortical activity and postural control for the first levodopa dose of the…Gut microbiota in patients with Parkinson’s disease (PD) predicts disease progression better than clinical features
Objective: To compare machine-learning models to predict the progression of PD using gut microbiota and clinical features. Background: A total of 21 studies including ours…The fear of progression of Parkinson’s Disease
Objective: Determine fear of progression (FoP) and its influencing factors in Parkinson's disease (PD) patients to alleviate the psychosocial distress it induces. Background: PD patients…Alternative Medications for Paroxysmal Kinesigenic Dyskinesia
Objective: Report the effectiveness of various medications in the treatment of paroxysmal kinesigenic dyskinesia (PKD). Background: PKD is an episodic movement disorder characterized by attacks…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.